Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR2 | O60603 | 3/20 | 0.40 |
| ▸ | KLK7 | P49862 | 2/20 | 0.39 |
| ▸ | KLK5 | Q9Y337 | 2/20 | 0.39 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.39 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.39 |
| ▸ | BCHE | P06276 | 2/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | TLR1 | Q15399 | 1/20 | 0.38 |
| ▸ | SIRT2 | Q8IXJ6 | 2/20 | 0.38 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.37 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.37 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.37 |
| ▸ | TGM2 | P21980 | 2/20 | 0.37 |
| ▸ | TGM6 | O95932 | 1/20 | 0.37 |
| ▸ | F13A1 | P00488 | 1/20 | 0.37 |
| ▸ | TGM1 | P22735 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31624468 | 1.00 | TLR2 (0.40) | TLR2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL31624378 | 0.93 | HDAC1 (0.42) | TLR2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL31624377 | 0.93 | HDAC1 (0.42) | TLR2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL31624560 | 0.90 | SIRT2 (0.46) | TLR2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL31624336 | 0.88 | SIRT2 (0.41) | KLK7KLK5BCHEACHESIRT2 | |
| SCHEMBL31631377 | 0.87 | SIRT2 (0.44) | KLK7KLK5BCHEACHESIRT2 | |
| SCHEMBL16538674 | 0.85 | TLR2 (0.54) | TLR2TLR1 | |
| SCHEMBL31624368 | 0.85 | HDAC1 (0.48) | TLR2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL31624497 | 0.85 | HDAC1 (0.48) | TLR2KLK7KLK5HDAC1HDAC2 | |
| SCHEMBL31624416 | 0.85 | SIRT2 (0.42) | KLK7KLK5BCHEACHESIRT2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025128626-A1 | HYBRID PEPTIDE COMPOUNDS HAVING A MODIFIED LYSINE RESIDUE | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |
| WO-2025128624-A2 | HYBRID PEPTIDE COMPOUNDS HAVING A SUBSTITUTED TRYPTOPHAN RESIDUE OR A TERMINAL SUBSTITUENT | CARMOT THERAPEUTICS, INC. (US) | 2025-06-19 | — | — | WO | disclosed |